D-0714-2022 Class II Terminated
FDA drug recall D-0714-2022 was initiated by Direct Rx on December 7, 2021 and is designated Class II. Reason for recall: Defective Container: Leaking containers. The recall status is terminated (terminated October 5, 2023). Affected quantity: 312 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- March 30, 2022
- Initiation Date
- December 7, 2021
- Termination Date
- October 5, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 312 bottles
Product Description
Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05
Reason for Recall
Defective Container: Leaking containers.
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: 24MA2010 Exp. 1/31/2023